These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 3079047

  • 1. The results of renal transplantation with cyclosporine in immunologically high-risk patients.
    Dickerman RM, Vergne-Marini P, Langley J, Trevino G, Velez R, Brinker K, Nesser D, Long D, Hull AR.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1846-8. PubMed ID: 3079047
    [No Abstract] [Full Text] [Related]

  • 2. Quadruple therapy for cadaver renal transplantation.
    Deierhoi MH, Sollinger HW, Kalayoglu M, Belzer FO.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1917-9. PubMed ID: 3274452
    [No Abstract] [Full Text] [Related]

  • 3. Potent immunosuppression overcomes retransplantation, presensitization, and historical positive crossmatch as transplant risk factors.
    Gaber AO, Thistlethwaite JR, Haag BW, Stuart J, Mayes J, Fellner S, Stuart FP.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1915-6. PubMed ID: 3274451
    [No Abstract] [Full Text] [Related]

  • 4. A comparison of renal biopsies in cyclosporine and conventionally immunosuppressed renal transplant recipients.
    Simonton SC, Sibley RK, Fryd DS.
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1790. PubMed ID: 3079038
    [No Abstract] [Full Text] [Related]

  • 5. Renal transplantation with cyclosporine in the elderly population.
    Velez RL, Brinker KR, Vergne-Marini PJ, Nesser DA, Long DL, Trevino G, Dickerman RM, Helfrich GB.
    Transplant Proc; 1991 Apr; 23(2):1749-52. PubMed ID: 1905073
    [No Abstract] [Full Text] [Related]

  • 6. High long-term graft survival rates in kidney transplantation with the sequential association of antithymocyte globulin and cyclosporine A monotherapy.
    Hourmant M, Buzelin F, Dubigeon P, Soulillou JP.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2113-4. PubMed ID: 3079073
    [No Abstract] [Full Text] [Related]

  • 7. Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone.
    Halloran P, Ludwin D, Bear R, Aprile M, McQuarrie B, Poole R, White N.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1931-2. PubMed ID: 3274454
    [No Abstract] [Full Text] [Related]

  • 8. High rate of success in kidney cadaveric retransplantation with optimal matching and potent immunosuppression.
    Hiesse C, Neyrat N, Busson M, Bensadoun H, Lantz O, Bellamy J, Benoit G, Charpentier B, Fries D.
    Transplant Proc; 1990 Aug; 22(4):1909-10. PubMed ID: 2389483
    [No Abstract] [Full Text] [Related]

  • 9. Conversion from cyclosporine to azathioprine improves renal function without increased risk of graft failure.
    Maddux MS, Veremis SA, Pollak R, Mozes MF.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2007-9. PubMed ID: 3079066
    [Abstract] [Full Text] [Related]

  • 10. Cox regression analysis of outcome risk factors in 519 renal allograft recipients.
    Canafax DM, Savik SK, Draxler CA, Le CT, Ascher NL, Payne WD, Sutherland DE, Migliori RJ, Simmons RL, Najarian JS.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1947-8. PubMed ID: 3274455
    [No Abstract] [Full Text] [Related]

  • 11. Use of antithymocyte globulin and cyclosporine to treat steroid-resistant rejection episodes in renal transplant recipients.
    Benvenisty AI, Tannenbaum GA, Cohen DJ, Appel G, Hardy MA.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1889-91. PubMed ID: 3274446
    [No Abstract] [Full Text] [Related]

  • 12. Cyclosporine immunosuppression and perfusion preservation of cadaver kidneys.
    Bradley JW, Cho SI, Cosimi AB, Monaco AP.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2104-5. PubMed ID: 3079072
    [No Abstract] [Full Text] [Related]

  • 13. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
    Gianello P, Squifflet JP, Pirson Y, Stoffel M, Dereme T, Alexandre GP.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
    Sommer BG, Henry ML, Ferguson RM.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1879-80. PubMed ID: 3274445
    [No Abstract] [Full Text] [Related]

  • 16. Place of antilymphocyte globulins in the immunosuppressive regimen for kidney transplantation.
    Touraine JL, Lefrançois N, Dubernard JM, Garnier JL, Eygonnet JP, Gibelin N, Bétuel H, Traeger J.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1881. PubMed ID: 3079055
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Improved immunosuppression for secondary cadaver renal transplants (SCT) in high risk patients using quadruple immunosuppression with cyclosporine A (CsA) and rabbit anti-thymocyte globulin (RATG).
    DeMasi R, Thomas F, Cunningham P, Sash C, Clark G, Thomas J.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1729-31. PubMed ID: 2652565
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Tolerance induction in human kidney retransplantation: impact of repeated HLA mismatches in 156 second renal grafts.
    Gnant MF, Sautner T, Rosenmayr A, Muehlbacher F.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):319-21. PubMed ID: 8438317
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.